Johnson and Johnson two-dose vaccine against Ebola safe, claims study MD Bureau16 Sep 2021 5:00 AM GMTLondon: The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune re...
Moderna COVID vaccine superior to Pfizer, JnJ against Delta, claims study MD Bureau11 Sep 2021 4:00 AM GMTNew York: Moderna's vaccine for Covid-19 is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson & ...
Covid-19: Aspen Pharmacare eyes Serum Institute model as it seeks licence to make JnJ vaccine ruchika4 Sep 2021 3:30 AM GMTJohannesburg: South Africa's Aspen Pharmacare wants to model itself on India's Serum Institute by getting a licence to manufacture Johnson & J...
JnJ HIV vaccine fails Imbokodo trial ruchika1 Sep 2021 11:24 AM GMTThe Imbokodo study showed a 25.2% vaccine efficacy, based on which, the drugmaker said the study will not continue.
Second dose provides strong boost against Covid-19: JnJ MD Bureau27 Aug 2021 3:30 AM GMTWashington: The second dose of Johnson & Johnson's Covid-19 vaccine generates a strong immune response against the deadly virus among people previo...
JnJ eyes CDSCO nod for single shot COVID vaccine trials in 12-17 year olds MD Bureau20 Aug 2021 6:10 AM GMTNew Delhi: The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO) ...
JnJ gets DCGI emergency use approval for single dose COVID vaccine ruchika7 Aug 2021 11:21 AM GMTNew Delhi: Johnson & Johnson's single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya...
Still in talks with Indian govt on COVID vaccine: Johnson and Johnson ruchika2 Aug 2021 12:26 PM GMTBengaluru: Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country's dru...
JnJ single-shot COVID vaccine shelf life extended by USFDA to 6 months ruchika29 July 2021 8:52 AM GMTNew Delhi: The U.S. Food & Drug Administration extended the shelf life for Johnson & Johnson's single-shot COVID-19 vaccine to six months ...
Despite neurological illness reports, JnJ Covid-19 vaccine benefits outweigh risks: US CDC advisers ruchika23 July 2021 7:15 AM GMTNew Delhi: Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the ben...
Strong quarter from Johnson and Johnson as some operations return to normal ruchika22 July 2021 4:00 AM GMTNew Delhi: Johnson & Johnson's second-quarter profit soared 73%, thanks to strong sales growth across all of its businesses, particularly its medic...
Johnson and Johnson exploring putting talc liabilities into bankruptcy: Report ruchika19 July 2021 10:00 AM GMTNew Delhi: Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that w...
